Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG α- and β-subunits, and their ratios | Zendy

Nienke E. van Trommel | Zendy; Fred C.G.J. Sweep | Zendy; Charles P.T. Schijf | Zendy; Leon F.A.G. Massuger | Zendy; Chris M.G. Thomas | Zendy

Open Access

Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG α- and β-subunits, and their ratios

Author(s) -

Nienke E. van Trommel,

Fred C.G.J. Sweep,

Charles P.T. Schijf,

Leon F.A.G. Massuger,

Chris M.G. Thomas

Publication year - 2005

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.1.01997

Subject(s) - human chorionic gonadotropin , partial hydatidiform mole , mole , molar pregnancy , gonadotropin , medicine , pregnancy , gestational trophoblastic disease , chorioepithelioma , trophoblastic neoplasm , choriocarcinoma , endocrinology , placenta , gynecology , gestation , biology , hormone , fetus , genetics

Human chorionic gonadotropin (hCG) is widely used in the management of hydatidiform mole and persistent trophoblastic disease (PTD). Predicting PTD after molar pregnancy might be beneficial since prophylactic chemotherapy reduces the incidence of PTD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research